Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 44 out of 100. How common it is

Topic: Risk, prevention and care in population studies

Identifying older adults at increased dementia risk is a public health priority. Existing scores often emphasize midlife factors or variables of limited utility in late life. We developed a late-life dementia risk score using data from the InveCe.Ab cohort, including 1100 dementia-free individuals aged 70–74 and followed for 12 years. Candidate risk and protective factors were selected based on systematic reviews and expert consensus. Stepwise Cox models were used to construct a weighted score with and without adjustment for non-modifiable factors. External validation was performed in the TRELONG cohort. The selected modifiable factors were diabetes, alcohol consumption, hypercholesterolemia, social participation, and cognitive activity, with strong predictive accuracy for dementia incidence (HR = 1.23; 95% CI 1.14–1.33; p < 0.026), also after adjustment for non-modifiable factors. In the TRELONG cohort, the score remained significant (HR = 1.19; 95% CI 1.05–1.10; p = 0.008), though its predictive value decreased when adjusting for non-modifiable factors. The LateDem-Risk score offers a practical tool for risk stratification in adults aged ≥ 70 years. Further studies are needed to evaluate its predictive performance in different settings and populations.

Key findings

Why it matters

A risk score built from factors like diabetes, alcohol consumption, cholesterol, social participation and cognitive activity predicted dementia in adults aged 70 and older in two Italian cohorts. The score is a practical tool for risk stratification, but further studies are needed to test how well it works in other settings and populations.

Study details

How this study scored 44/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 44 of 100.44 of 100 points earned56 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific Reports)
Journal's citation record 3 / 4 Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.0 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 9.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Elena Rolandi: h-index 24 (OpenAlex, whole career)
Institution's track record 0 / 3 Istituto Superiore di Sanità: institution h-index 523 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41691016)
Free to read 2 / 2 Free to read
Total 44 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Rossi, M., Brianzoni, I., Colombo, M., Davin, A., Gallucci, M., Guaita, A., et al. (2026). Development and validation of the LateDem-Risk score to predict dementia incidence in the InveCe.Ab and Trelong Italian cohorts. Scientific Reports. https://doi.org/10.1038/s41598-026-39205-z

Vancouver

Rossi M, Brianzoni I, Colombo M, Davin A, Gallucci M, Guaita A, et al. Development and validation of the LateDem-Risk score to predict dementia incidence in the InveCe.Ab and Trelong Italian cohorts. Scientific Reports. 2026. doi:10.1038/s41598-026-39205-z. PMID: 41691016.

BibTeX

@article{rossi2026-41691016,
  author  = {Rossi, Michele and Brianzoni, Irene and Colombo, Mauro and Davin, Annalisa and Gallucci, Maurizio and Guaita, Antonio and Vanacore, N. and Rolandi, Elena},
  title   = {{Development and validation of the LateDem-Risk score to predict dementia incidence in the InveCe.Ab and Trelong Italian cohorts}},
  journal = {Scientific Reports},
  year    = {2026},
  doi     = {10.1038/s41598-026-39205-z},
  pmid    = {41691016},
  url     = {https://doi.org/10.1038/s41598-026-39205-z}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.

Related studies in How common it is

Similar studies

More on How common it is

See all studies in How common it is →